2cureX AB (2CUREX)

Currency in SEK
2.19
-0.01(-0.45%)
Closed·
2CUREX Scorecard
Full Analysis
Net income is expected to grow this year
2CUREX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.132.19
52 wk Range
0.335.52
Key Statistics
Prev. Close
2.2
Open
2.19
Day's Range
2.13-2.19
52 wk Range
0.33-5.52
Volume
4.34K
Average Volume (3m)
370.71K
1-Year Change
294.59%
Book Value / Share
0.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2CUREX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

2cureX AB Company Profile

2cureX AB (publ) operates as a medtech company in Europe. The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.

Compare 2CUREX to Peers and Sector

Metrics to compare
2CUREX
Peers
Sector
Relationship
P/E Ratio
−3.2x−4.2x−0.5x
PEG Ratio
−0.19−0.200.00
Price/Book
30.2x6.0x2.6x
Price / LTM Sales
42.6x6.5x3.3x
Upside (Analyst Target)
-161.2%43.5%
Fair Value Upside
Unlock5.3%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1.50%
Dividend Yield
3.84%
Industry Median 50.25%
Annualised payout
0.08
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 22, 2024
EPS / Forecast
-0.54 / --
Revenue / Forecast
500.00K / --
EPS Revisions
Last 90 days

2CUREX Income Statement

FAQ

What Stock Exchange Does 2cureX Trade On?

2cureX is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for 2cureX?

The stock symbol for 2cureX is "2CUREX."

What Is the 2cureX Market Cap?

As of today, 2cureX market cap is 54.98M.

What Is 2cureX's Earnings Per Share (TTM)?

The 2cureX EPS (TTM) is -1.50.

From a Technical Analysis Perspective, Is 2CUREX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has 2cureX Stock Split?

2cureX has split 1 times.

How Many Employees Does 2cureX Have?

2cureX has 14 employees.

What is the current trading status of 2cureX (2CUREX)?

As of 09 Aug 2025, 2cureX (2CUREX) is trading at a price of 2.19, with a previous close of 2.20. The stock has fluctuated within a day range of 2.13 to 2.19, while its 52-week range spans from 0.33 to 5.52.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.